Tech Mahindra Reports 32.7% Profit Surge in Q2 Earnings

Tech Mahindra leads the stock market focus today with impressive quarterly results, alongside significant updates from other companies.

A
Aapla Nagpur Desk
16 Oct 2026, 6:43 AM IST · 2 min read
Source: Moneycontrol
Tech Mahindra Reports 32.7% Profit Surge in Q2 Earnings
KEY TAKEAWAYS
1

Tech Mahindra's profit increased by 32.7% to Rs 1,585.6 crore in Q2.

2

IIFL Finance saw a profit surge of 103.7% to Rs 766.4 crore.

3

Mankind Pharma is set to acquire a majority stake in a Belgian biotech firm for €48 million.

On October 16, Tech Mahindra announced a remarkable 32.7% increase in its second-quarter profit, reaching Rs 1,585.6 crore compared to Rs 1,194.5 crore last year. The company also reported a revenue growth of 15.6%, totaling Rs 16,180.2 crore. Additionally, Tech Mahindra's board declared an interim dividend of Rs 15 per share and approved a bonus equity share issue in a 1:1 ratio, highlighting its strong financial performance.

In the broader context of the stock market, several companies are set to release their quarterly earnings today, including Punjab National Bank, Bajaj Housing Finance, and DLF. Tomorrow, major banks such as HDFC Bank and ICICI Bank will announce their results, which are anticipated to influence market trends significantly.

IIFL Finance also reported impressive results, with profits soaring 103.7% to Rs 766.4 crore, driven by a 50.2% increase in net interest income. Meanwhile, Persistent Systems experienced a decline in profit by 25.4% to Rs 351.5 crore, despite a revenue increase of 30.3% to Rs 4,663.9 crore. This mixed performance among tech firms reflects the varying challenges and opportunities within the sector.

The implications of these earnings reports are significant for investors and the market at large. Tech Mahindra's strong results may boost investor confidence, while IIFL Finance's growth signals a robust demand for financial services. Mankind Pharma's acquisition of a majority stake in Armed Cell Therapeutics for €48 million indicates a strategic move towards expanding its portfolio in the biotechnology sector, which could enhance its market position.

Looking ahead, investors will be keenly observing the upcoming earnings announcements from major banks on October 17, as these results are likely to shape market sentiment. Additionally, the ongoing developments in the tech and finance sectors will be crucial for understanding future market dynamics and investment opportunities.

💬What did you think of this story?What did you think?

Read Next